Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04835584
Title KRT-232 and TKI Study in Chronic Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Kartos Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | POL | ITA | FRA | ESP | CAN

Additional content available in CKB BOOST